{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:47:46Z","timestamp":1783734466573,"version":"3.55.0"},"reference-count":17,"publisher":"Western Journal of Emergency Medicine","issue":"5","license":[{"start":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T00:00:00Z","timestamp":1629590400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WestJEM"],"abstract":"<jats:p>Introduction: Management of sedation, analgesia, and anxiolysis are cornerstone therapies in the emergency department (ED). Dexmedetomidine (DEX), a central alpha-2 agonist, is increasingly being used, and intensive care unit (ICU) data demonstrate improved outcomes in patients with respiratory failure. However, there is a lack of ED-based data. We therefore sought to: 1) characterize ED DEX use; 2) describe the incidence of adverse events; and 3) explore factors associated with adverse events among patients receiving DEX in the ED.\n\nMethods: This was a single-center, retrospective, cohort study of consecutive ED patients administered DEX (January 1, 2017\u2013July 1, 2019) at an academic, tertiary care ED with an annual census of ~90,000 patient visits. All included patients (n= 103) were analyzed for characterization of DEX use in the ED. The primary outcome was a composite of adverse events, bradycardia and hypotension. Secondary clinical outcomes included ventilator-, ICU-, and hospital-free days, and hospital mortality. To examine for variables associated with adverse events, we used a multivariable logistic regression model.\n\nResults: We report on 103 patients. Dexmedetomidine was most commonly given for acute respiratory failure, including sedation for mechanical ventilation (28.9%) and facilitation of non-invasive ventilation (17.4%). Fifty-four (52.4%) patients experienced the composite adverse event, with hypotension occurring in 41 patients (39.8%) and bradycardia occurring in 18 patients (17.5%). Dexmedetomidine was stopped secondary to an adverse event in eight patients (7.8%). Duration of DEX use in the ED was associated with an increase adverse event risk (adjusted odds ratio, 1.004; 95% confidence interval, 1.001, 1.008).\n\nConclusion: Dexmedetomidine is most commonly administered in the ED for patients with acute respiratory failure. Adverse events are relatively common, yet DEX is discontinued comparatively infrequently due to adverse events. Our results suggest that DEX could be a viable option for analgesia, anxiolysis, and sedation in ED patients.<\/jats:p>","DOI":"10.5811\/westjem.2021.4.50917","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:54:03Z","timestamp":1631580843000},"page":"1202-1209","source":"Crossref","is-referenced-by-count":11,"title":["The Use of Dexmedetomidine in the Emergency Department: A Cohort Study"],"prefix":"10.5811","volume":"22","author":[{"given":"Joseph","family":"Sinnott","sequence":"first","affiliation":[{"name":"Washington University School of Medicine in St. Louis, Department of Emergency Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Holthaus","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine in St. Louis, Department of Emergency Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enyo","family":"Ablordeppey","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine in St. Louis, Department of Emergency Medicine, St. Louis, Missouri; Washington University School of Medicine in St. Louis, Department of Anesthesiology, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Wessman","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine in St. Louis, Department of Emergency Medicine, St. Louis, Missouri; Washington University School of Medicine in St. Louis, Department of Anesthesiology, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Roberts","sequence":"additional","affiliation":[{"name":"Cooper University Hospital, Department of Emergency Medicine, Camden, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Fuller","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine in St. Louis, Department of Emergency Medicine, St. Louis, Missouri; Washington University School of Medicine in St. Louis, Department of Anesthesiology, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3840","published-online":{"date-parts":[[2021,8,22]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Huang Z, Chen Y-S, Yang Z-l, et al. Dexmedetomidine versus midazolam for the sedation of patients with non-invasive ventilation failure. Intern Med. 2012;51(17):2299-305.","DOI":"10.2169\/internalmedicine.51.7810"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Jakob S, Ruokonen E, Grounds RM, et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA. 2012;307(11):1151-60.","DOI":"10.1001\/jama.2012.304"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Riker R, Shehabi Y, Bokesch P. SEDCOM (Safety and Efficacy of Dexmedetomidine Compared with Midazolam) Study Group Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA. 2009;3015:489-99.","DOI":"10.1001\/jama.2009.56"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007;298(22):2644-53.","DOI":"10.1001\/jama.298.22.2644"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Senoglu N, Oksuz H, Dogan Z, et al. Sedation during noninvasive mechanical ventilation with dexmedetomidine or midazolam: a randomized, double-blind, prospective study. Curr Ther Res Clin Exp. 2010;71(3):141-53.","DOI":"10.1016\/j.curtheres.2010.06.003"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Long D, Long B, Koyfman A. The emergency medicine management of severe alcohol withdrawal. Am J Emerg Med. 2017;35(7):1005-11.","DOI":"10.1016\/j.ajem.2017.02.002"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Godwin SA, Burton JH, Gerardo CJ, et al. Clinical policy: procedural sedation and analgesia in the emergency department. Ann Emerg Med. 2014;63(2):247-58e18.","DOI":"10.1016\/j.annemergmed.2013.10.015"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Jewett J, Phillips WJ. Dexmedetomidine for procedural sedation in the emergency department. Eur J Emerg Med. 2010;17(1):60.","DOI":"10.1097\/MEJ.0b013e3283325ec2"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Masoumi K, Maleki SJ, Forouzan A, et al. Dexmedetomidine versus midazolam-fentanyl in procedural analgesia sedation for reduction of anterior shoulder dislocation: a randomized clinical trial. Rev Recent Clin Trials. 2019;14(4):269-74.","DOI":"10.2174\/1574887114666190809160419"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. Ann Intern Med. 2007;147(8):573-7.","DOI":"10.7326\/0003-4819-147-8-200710160-00010"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Leisman DE, Harhay MO, Lederer DJ, et al. Development and reporting of prediction models: guidance for authors from editors of respiratory, sleep, and critical care journals. Crit Care Med. 2020;48(5):623.","DOI":"10.1097\/CCM.0000000000004246"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Peduzzi P, Concato J, Feinstein AR, et al. Importance of events per independent variable in proportional hazards regression analysis II. Accuracy and precision of regression estimates. J Clin Epidemiol. 1995;48(12):1503-10.","DOI":"10.1016\/0895-4356(95)00048-8"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373-9.","DOI":"10.1016\/s0895-4356(96)00236-3"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Calver L, Isbister GK. Dexmedetomidine in the emergency department: assessing safety and effectiveness in difficult-to-sedate acute behavioural disturbance. Emerg Med J. 2012;29(11):915-8.","DOI":"10.1136\/emermed-2011-200849"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Jakob SM, Lubszky S, Friolet R, et al. Sedation and weaning from mechanical ventilation: effects of process optimization outside a clinical trial. J Crit Care. 2007;22(3):219-28.","DOI":"10.1016\/j.jcrc.2007.01.001"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Zhou Y, Jin X, Kang Y, et al. Midazolam and propofol used alone or sequentially for long-term sedation in critically ill, mechanically ventilated patients: a prospective, randomized study. Crit Care. 2014;18(3):1-9.","DOI":"10.1186\/cc13922"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Morelli A, Sanfilippo F, Arnemann P, et al. The effect of propofol and dexmedetomidine sedation on norepinephrine requirements in septic shock patients: a crossover trial. Crit Care Med. 2019;47(2):e89-e95.","DOI":"10.1097\/ccm.0000000000003520"}],"container-title":["Western Journal of Emergency Medicine"],"original-title":[],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:54:13Z","timestamp":1631580853000},"score":1,"resource":{"primary":{"URL":"https:\/\/escholarship.org\/uc\/item\/1v0402j7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,22]]},"references-count":17,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,9,7]]}},"URL":"https:\/\/doi.org\/10.5811\/westjem.2021.4.50917","relation":{},"ISSN":["1936-900X"],"issn-type":[{"value":"1936-900X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,22]]}}}